1. Home
  2. ALTG vs IKT Comparison

ALTG vs IKT Comparison

Compare ALTG & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alta Equipment Group Inc.

ALTG

Alta Equipment Group Inc.

HOLD

Current Price

$5.87

Market Cap

236.8M

Sector

Industrials

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$2.42

Market Cap

220.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTG
IKT
Founded
1984
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.8M
220.5M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
ALTG
IKT
Price
$5.87
$2.42
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$11.33
$5.00
AVG Volume (30 Days)
144.8K
476.0K
Earning Date
05-07-2026
03-26-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
57.76
EPS
N/A
N/A
Revenue
$1,835,900,000.00
N/A
Revenue This Year
$4.85
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$1.33
52 Week High
$8.69
$2.54

Technical Indicators

Market Signals
Indicator
ALTG
IKT
Relative Strength Index (RSI) 43.18 57.84
Support Level $5.98 $2.31
Resistance Level $6.57 $2.53
Average True Range (ATR) 0.36 0.10
MACD -0.11 -0.01
Stochastic Oscillator 13.02 58.70

Price Performance

Historical Comparison
ALTG
IKT

About ALTG Alta Equipment Group Inc.

Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling, Construction Equipment, and Master Distribution. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, Pennsylvania, New York, Florida and throughout the New England States, and The Master Distribution segment is engaged in environmental processing equipment distribution with sub dealers throughout the United States and Canada.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

Share on Social Networks: